Investors

Trust Stamp is an artificial intelligence company that primarily develops proprietary identity solutions to help determine whether an individual is who they say they are and that they can be trusted, including Trust Stamp’s AI-powered facial biometrics that establish proof of life and are resistant to presentation attacks. The Group’s solutions revolve around a proprietary process by which a deep neural network irreversibly converts biometric and other identifying data, from any source, into an Irreversibly Transformed Identity Token (IT2) that can be matched, deduplicated and verified while protecting sensitive identity information. This hash is unique to the user but cannot be reverse engineered and rebuilt into the user’s face or other biometric data.

Names of Directors and Biographical Details
David Story

David Story

Executive Chairman
Gareth Genner

Gareth Genner

Chief Executive Officer
Andrew Gowasack

Andrew Gowasack

President
Mark Birschbach

Mark Birschbach

Independent Non-Executive Director
Joshua Allen

Joshua Allen

Executive Director
William ("Bill") McClintock

William ("Bill") McClintock

Independent Non-Executive Director
Board Committees

The Board has established an Audit Committee, a Remuneration Committee, a Nomination Committee and a Disclosure Committee, with formally delegated responsibilities as described below.

The Audit Committee comprises a majority of Independent Non-Executive Directors. The Audit Committee will, inter alia, determine and examine matters relating to the financial affairs of the Company including the terms of engagement of the Company’s auditors and, in consultation with the auditors, the scope of the annual audit. It will receive and review reports from management and the Company’s auditors relating to the half yearly and annual accounts and the accounting and internal control systems in use throughout the Group.

The Remuneration Committee will, inter alia, review and make recommendations in respect of the Directors’ remuneration and benefits packages, including share options and Board Committees

The Nomination Committee will be chaired by Mark Birschbach. The Nomination Committee will consider the selection and re-appointment of Directors. It will identify and nominate candidates to fill Board vacancies and review regularly the structure, size and composition (including the skills, knowledge and experience) of the Board and make recommendations to the Board with regard to any changes, identifying and nominating for Board approval members of the Board, succession planning for Board members and overseeing the evaluation of the Board.

The Disclosure Committee comprises Chief Executive Officer, Gareth Genner, and the Chief Financial Officer and Secretary, Alex Valdes. The Disclosure Committee will be responsible for ensuring that the Company makes timely and accurate disclosure of all information that is required to be disclosed to meet its disclosure obligations under the OTCQX Reporting Standard, Market Abuse Regulation, and the Euronext Growth Rules.

Corporate Governance

The Directors recognise the importance of sound corporate governance and, given the Group’s size and constitution of the Board, complies with the principles set out in the OTCQX Corporate Governance Code. The OTCQX Corporate Governance Code was devised by the OTC Markets Group to align with established regulatory standards and exchange industry best practices.

Country of Incorporation & Main Country of Operation

T Stamp Inc. is incorporated in the State of Delaware in the U.S, with its principal operations in the U.S, & the UK. The rights of the shareholders are governed by Delaware law and by the Company's amended and restated certificate of incorporate and bylaws may be different from the rights of shareholders in an Irish incorporated company.

Current Constitutional Documents
Details of other exchanges or trading platforms

The company’s 3,588,651 shares of Class A Common Stock are admitted to trading on the Euronext Growth market of Euronext Dublin.

Details, if any, of restriction on the transfer of shares

There are no restrictions on the transfer of Common Shares.

Number of admitted securities in issue, % of admitted securities not in public hands[Last updated: 8 December 2020]

Shares of Class A Common Stock in issue: 3,588,651

Percent not in public hands: 55.6%

Significant shareholders[Last updated: 8 December 2020]
ShareholderCommon Shares HeldShareholding %
FSH Capital LLC505,24714.1%
Brent De Jong274,4937.7%
Andrew Gowasack243,0866.8%
Gareth Genner203,3195.7%
10Clouds121,9523.4%
Takeover Rules

The Company is incorporated in the State of Delaware in the United States and, for purposes of the Irish Takeover Rules, the Company is not resident in Ireland. As a result, although the Common Shares will be admitted to trading on Euronext Growth, the Company is not subject to the provisions of the Irish Takeover Rules.

Financial Information
Historical financial information for 2017, 2018, 2019 and the six month period to 30 June 2020 can be found in the Company’s Admission Document.
Advisers
Nominated Adviser, Euronext Growth Adviser & Joint Broker

Davy

Davy House 49 Dawson Street Dublin 2, D02 PY05 Ireland

Irish Legal Advisor

William Fry

2 Grand Canal Square Dublin 2 D02 A342

US Legal Advisor

CrowdCheck Law LLP

1423 Leslie Ave, Alexandria, VA 22301 United States

Auditor to the Company

Cherry Bekaert

Certified public accounting firm 1075 Peachtree Street NE, Suite 2200 Atlanta, GA 30309 United States

Registrar

Euroclear UK & Ireland Limited

33 Cannon Street London EC4M 5SB United Kingdom

Headquarters
3017 Bolling Way NE Floors 1 and 2 Atlanta, GA 30305 United States